Sulfonylpyrroles as histone deacetylase inhibitors

Details for Australian Patent Application No. 2006232773 (hide)

Owner 4SC AG

Inventors Maier, Thomas; Zimmermann, Astrid; Gekeler, Volker; Dullweber, Frank; Baer, Thomas; Beckers, Thomas

Agent Griffith Hack

Pub. Number AU-B-2006232773

PCT Pub. Number WO2006/105979

Priority 05102750.6 07.04.05 EP

Filing date 7 April 2006

Wipo publication date 12 October 2006

Acceptance publication date 12 April 2012

International Classifications

C07D 207/48 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

29 November 2007 PCT application entered the National Phase

  PCT publication WO2006/105979 Priority application(s): WO2006/105979

31 January 2008 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor from Bar, Thomas to Baer, Thomas

2 October 2008 Assignment before Grant

  Nycomed GmbH The application has been assigned to 4SC AG

12 April 2012 Application Accepted

  Published as AU-B-2006232773

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006232774-Device for dosing and dry nebulization

2006232747-Substituted 1,5-naphthyridine azolidinones as CDK inhibitors